# OnCo record docetaxel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/docetaxel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "docetaxel" ;
  schema:name "Docetaxel"@en ;
  schema:description "The first chemotherapy to extend life in prostate cancer (2004), now part of triplet therapy at first metastatic diagnosis."@en ;
  schema:url <https://onco.cc/drugs/docetaxel/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Docetaxel> ;
  owl:sameAs <http://www.wikidata.org/entity/Q420436> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Docetaxel>, <https://www.nice.org.uk/guidance/ta101>, <https://doi.org/10.1056/NEJMoa040720> ;
  onco:status "approved" ;
  onco:modality "Cytotoxic chemotherapy (taxane)" ;
  schema:alternateName "Taxotere (generic)" ;
  onco:approval "US 1996: Locally advanced or metastatic breast cancer after chemotherapy (Taxotere, NDA 020449)", "US 2004: Metastatic CRPC (with prednisone)" ;
  onco:acceleratedApproval "US 1996-05-14: Locally advanced or metastatic breast carcinoma that progressed during anthracycline-based therapy or relapsed during anthracycline-based adjuvant therapy" ;
  onco:acceleratedApprovalConfirmed "US 1998-06-22: Locally advanced or metastatic breast carcinoma that progressed during anthracycline-based therapy or relapsed during anthracycline-based adjuvant therapy" ;
  onco:related <https://onco.cc/technologies/acupuncture-chemotherapy-neuropathy/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/prostate-mhspc/>, <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-metastatic/>, <https://onco.cc/cancers/tnbc-early/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:terms <https://onco.cc/terms/prostate-crpc-sequencing/> ;
  onco:trials <https://onco.cc/trials/chaarted/>, <https://onco.cc/trials/stampede/>, <https://onco.cc/trials/peace-1/>, <https://onco.cc/trials/arasens/>, <https://onco.cc/trials/nct05089734/>, <https://onco.cc/trials/nct06340568/>, <https://onco.cc/trials/nct06382129/>, <https://onco.cc/trials/nct05348577/>, <https://onco.cc/trials/nct06520345/>, <https://onco.cc/trials/nct07518173/>, <https://onco.cc/trials/nct06699212/>, <https://onco.cc/trials/nct06356311/>, <https://onco.cc/trials/nct06928389/>, <https://onco.cc/trials/nct06989112/>, <https://onco.cc/trials/nct06300177/>, <https://onco.cc/trials/nct07213674/>, <https://onco.cc/trials/nct06976190/>, <https://onco.cc/trials/nct06952504/>, <https://onco.cc/trials/nct06118333/>, <https://onco.cc/trials/nct01933932/>, <https://onco.cc/trials/nct06925737/>, <https://onco.cc/trials/nct02486718/>, <https://onco.cc/trials/nct06074588/>, <https://onco.cc/trials/nct07291037/>, <https://onco.cc/trials/nct07196774/>, <https://onco.cc/trials/nct06881784/>, <https://onco.cc/trials/nct06891833/>, <https://onco.cc/trials/nct07287150/>, <https://onco.cc/trials/nct04140526/>, <https://onco.cc/trials/nct07306624/>, <https://onco.cc/trials/nct05676931/>, <https://onco.cc/trials/nct04895709/>, <https://onco.cc/trials/nct06463665/>, <https://onco.cc/trials/nct05904379/>, <https://onco.cc/trials/nct06943820/>, <https://onco.cc/trials/nct05431270/>, <https://onco.cc/trials/nct06568094/>, <https://onco.cc/trials/nct06445400/>, <https://onco.cc/trials/nct07590934/>, <https://onco.cc/trials/nct07246863/>, <https://onco.cc/trials/nct02861573/>, <https://onco.cc/trials/nct05126719/>, <https://onco.cc/trials/nct06228326/>, <https://onco.cc/trials/nct07070440/>, <https://onco.cc/trials/nct05020457/>, <https://onco.cc/trials/nct07102381/>, <https://onco.cc/trials/nct06841055/>, <https://onco.cc/trials/nct05910827/>, <https://onco.cc/trials/nct05592626/>, <https://onco.cc/trials/nct05054439/>, <https://onco.cc/trials/nct05427383/>, <https://onco.cc/trials/nct06908304/>, <https://onco.cc/trials/nct05296798/>, <https://onco.cc/trials/nct07415031/>, <https://onco.cc/trials/nct06057610/>, <https://onco.cc/trials/nct05999994/>, <https://onco.cc/trials/nct07419295/>, <https://onco.cc/trials/nct05094336/>, <https://onco.cc/trials/nct06783647/>, <https://onco.cc/trials/nct03671044/>, <https://onco.cc/trials/nct04025879/>, <https://onco.cc/trials/nct05867420/>, <https://onco.cc/trials/nct07518147/>, <https://onco.cc/trials/nct06857175/>, <https://onco.cc/trials/nct06863272/>, <https://onco.cc/trials/nct06745908/>, <https://onco.cc/trials/nct06545955/>, <https://onco.cc/trials/nct03505320/>, <https://onco.cc/trials/nct00781612/>, <https://onco.cc/trials/nct06947291/>, <https://onco.cc/trials/nct06682780/>, <https://onco.cc/trials/nct06780098/>, <https://onco.cc/trials/nct06644781/>, <https://onco.cc/trials/nct07225946/>, <https://onco.cc/trials/nct06353386/>, <https://onco.cc/trials/nct05173987/>, <https://onco.cc/trials/nct06016062/>, <https://onco.cc/trials/nct06632951/>, <https://onco.cc/trials/nct05631262/>, <https://onco.cc/trials/nct07669415/>, <https://onco.cc/trials/nct06012435/>, <https://onco.cc/trials/nct06123494/>, <https://onco.cc/trials/nct06296706/>, <https://onco.cc/trials/nct06741644/>, <https://onco.cc/trials/nct04634877/>, <https://onco.cc/trials/nct06663137/>, <https://onco.cc/trials/tnt/>, <https://onco.cc/trials/neopact/>, <https://onco.cc/trials/checkmate-017/>, <https://onco.cc/trials/checkmate-057/>, <https://onco.cc/trials/oak/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tpextreme-lancet-oncol-2021/> .